WallStSmart
GLMD

Galmed Pharmaceuticals Ltd

NASDAQ: GLMD · HEALTHCARE · BIOTECHNOLOGY

$0.58
-4.67% today

Updated 2026-06-05

Market cap
$4.59M
P/E ratio
P/S ratio
61.38x
EPS (TTM)
$-2.39
Dividend yield
52W range
$0 – $2
Volume
3.8M

Galmed Pharmaceuticals Ltd (GLMD) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20122013201420152016201720182019202020212022202320242025
Operating cash flow$-3.08M$-2.52M$-9.24M$-8.47M$-12.13M$-12.07M$-9.02M$-14.94M$-26.29M$-32.89M$-18.50M$-6.14M$-5.88M$-6.32M
Capital expenditures$32000.00$13000.00$770000.00$159000.00$17000.00$21000.00$90000.00$12000.00$44000.00$11000.00$4000.00$0.00$0.00$0.00
Depreciation$5000.00$4000.00$9000.00$50000.00$169000.00$239000.00$387000.00$35000.00$39000.00$42000.00$35000.00$31000.00$83000.00
Stock-based comp$208000.00$10.85M$601000.00$970000.00$1.63M$1.39M$1.78M$2.23M$2.07M$1.89M$1.30M$892000.00$531000.00$546000.00
Free cash flow$-3.11M$-2.54M$-10.01M$-8.63M$-12.15M$-12.09M$-9.11M$-14.95M$-26.33M$-32.90M$-18.50M$-6.14M$-5.88M$-6.32M
Investing cash flow$-32000.00$3000.00$-9.02M$-11.11M$6.34M$6.44M$-60.02M$6.68M$16.54M$11.46M$17.56M$800000.00$-1.11M
Financing cash flow$3.68M$1.94M$41.86M$4.73M$4.73M$15.55M$80.18M$143000.00$768000.00$17.37M$70000.00$6.18M$8.79M
Dividends paid
Share repurchases
Debt repayment
Net change in cash

Frequently asked questions

How much free cash flow does GLMD generate?

GLMD produced $-6.32M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is GLMD's balance sheet healthy?

GLMD holds $3.98M in cash and equivalents against — in long-term debt, on $15.78M of shareholder equity. That debt is best read against the cash flow the business throws off each year.